On April 23, 2026, the Vietnam Food Administration (VFA) issued a critical warning regarding the consumption of infant nutritional products... Read more
Category: Uncategorized
Vietnam – South Korea Medical Partnership: Expanding Links in Pharma, Food Safety, and High-Tech
On April 22, 2026, Minister of Health Dao Hong Lan chaired a high-level meeting and signed a Memorandum of Understanding... Read more
Strategic Setback for Merck: Lead Kidney Cancer Drug Fails Pivotal First-Line Trial
On April 21, 2026, Merck & Co. announced that its rapidly ascending drug, Welireg, failed to meet the primary endpoints... Read more
Serif Biomedicines: A New Frontier in “Modified DNA” Genetic Therapies
On April 21, 2026, Flagship Pioneering officially launched Serif Biomedicines, a biotech startup armed with $50 million in funding. The... Read more
2026-2030 Vision: Ziaja Vietnam’s Sustainability and CSR Strategy
For the 2026-2030 period, EUPC Group and its strategic partner Baniphar have established sustainability as their core developmental pillar. This... Read more
Leadership Succession: TNH Hospital Group Announces New Chairmanship
On April 21, 2026, TNH Hospital Group officially announced a significant shift in its senior leadership. This transition is framed... Read more
Ownership Restructuring: DHG’s Challenges in Sustaining Public Company Status
During the Annual General Meeting held on April 21, 2026, DHG Pharma (Stock Code: DHG) addressed legal hurdles regarding its... Read more
Elevating Testing Standards: Regulatory Reforms to Ensure National Pharmaceutical Security
On the afternoon of April 21, 2026, the Ministry of Health held a pivotal meeting to discuss amendments to Circular... Read more
Administrative Enforcement: 37 Cosmetic Products Recalled Due to Regulatory Non-Compliance
On April 21, 2026, the Drug Administration of Vietnam issued a formal sanction against a Hanoi-based distributor following a regulatory... Read more








